Naltrexone is actually an opioid antagonist applied in several conditions, either licensed or unlicensed. It is implemented at extensively different dosages from 3 to 250 mg. The objective of this analysis was to broadly examine the safeness of oral naltrexone by evaluating the potential risk of severe adverse events and negative events in random operated studies of naltrexone compared to placebo. A thorough search of the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, different database sources and clinical studies registries was attempted up to May 2018. Parallel placebo-controlled random controlled studies lengthier as compared to 4 weeks released after 1 January 2001 of oral naltrexone at any dosage had been chosen. A...
<p><i>Background</i>: ALO-02, comprising pellets of extended-release oxycodone surrounding sequester...
To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse preventio...
Background: Opioids are considered one of the most effective analgesics. However, knowledge on opioi...
Abstract Background Naltrexone is an opioid antagonist used in many different conditions, both licen...
Objectives: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
Aims: To compare the benefits and harms of naltrexone–bupropion using evidence from clinical study r...
Background: Naltrexone is a competitive opioid receptor antagonist blocking the euphoric effects of ...
Adverse events of opioids may restrict their use in non-cancer pain. Analysis of the incidence of co...
Background: North America is in the midst of an unabated opioid overdose epidemic d...
OBJECTIVES: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
Background: The rapid increase in prescribing and use of opioids for noncancer pain has coincided wi...
PURPOSE: Opioid dependence (OD) is a serious and growing clinical condition with increasing social c...
Methadone, which is a highly addictive drug. Naltrexone is a long-acting, opioid-antagonist that blo...
Aims: The study estimated serious adverse event (SAE) rates among entrants to pharmacotherapies for ...
The continued rise in the availability of illicit opioids and opioid-related deaths in the United St...
<p><i>Background</i>: ALO-02, comprising pellets of extended-release oxycodone surrounding sequester...
To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse preventio...
Background: Opioids are considered one of the most effective analgesics. However, knowledge on opioi...
Abstract Background Naltrexone is an opioid antagonist used in many different conditions, both licen...
Objectives: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
Aims: To compare the benefits and harms of naltrexone–bupropion using evidence from clinical study r...
Background: Naltrexone is a competitive opioid receptor antagonist blocking the euphoric effects of ...
Adverse events of opioids may restrict their use in non-cancer pain. Analysis of the incidence of co...
Background: North America is in the midst of an unabated opioid overdose epidemic d...
OBJECTIVES: To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relap...
Background: The rapid increase in prescribing and use of opioids for noncancer pain has coincided wi...
PURPOSE: Opioid dependence (OD) is a serious and growing clinical condition with increasing social c...
Methadone, which is a highly addictive drug. Naltrexone is a long-acting, opioid-antagonist that blo...
Aims: The study estimated serious adverse event (SAE) rates among entrants to pharmacotherapies for ...
The continued rise in the availability of illicit opioids and opioid-related deaths in the United St...
<p><i>Background</i>: ALO-02, comprising pellets of extended-release oxycodone surrounding sequester...
To investigate the clinical effectiveness and cost-effectiveness of naltrexone for relapse preventio...
Background: Opioids are considered one of the most effective analgesics. However, knowledge on opioi...